Nucleic acid molecule encoding antigen associated with lyme disease

US5686267A · kind A · utility

Assignees

• Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US
• DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS · DE

Inventors

• Markus Simon · Buckenhof, DE
• Ulrich E. Schaible · Freiberg, DE
• Klaus Eichmann · Glückstadt, DE
• Michael Kramer · Freiberg, DE
• Wallich Reinhard · Heidelberg, DE

Key dates

• Filing date: Mar 20, 1995
• Grant date: Nov 11, 1997
• Expiry date: Mar 20, 2015

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.